These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

532 related items for PubMed ID: 16030067

  • 1. Ghrelin receptor agonist GHRP-2 prevents arthritis-induced increase in E3 ubiquitin-ligating enzymes MuRF1 and MAFbx gene expression in skeletal muscle.
    Granado M, Priego T, Martín AI, Villanúa MA, López-Calderón A.
    Am J Physiol Endocrinol Metab; 2005 Dec; 289(6):E1007-14. PubMed ID: 16030067
    [Abstract] [Full Text] [Related]

  • 2. Experimental arthritis inhibits the insulin-like growth factor-I axis and induces muscle wasting through cyclooxygenase-2 activation.
    Granado M, Martín AI, Villanúa MA, López-Calderón A.
    Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1656-65. PubMed ID: 17284570
    [Abstract] [Full Text] [Related]

  • 3. Tumour necrosis factor blockade did not prevent the increase of muscular muscle RING finger-1 and muscle atrophy F-box in arthritic rats.
    Granado M, Martín AI, Priego T, López-Calderón A, Villanúa MA.
    J Endocrinol; 2006 Oct; 191(1):319-26. PubMed ID: 17065414
    [Abstract] [Full Text] [Related]

  • 4. GHRP-2, a GHS-R agonist, directly acts on myocytes to attenuate the dexamethasone-induced expressions of muscle-specific ubiquitin ligases, Atrogin-1 and MuRF1.
    Yamamoto D, Ikeshita N, Matsubara T, Tasaki H, Herningtyas EH, Toda K, Iida K, Takahashi Y, Kaji H, Chihara K, Okimura Y.
    Life Sci; 2008 Feb 27; 82(9-10):460-6. PubMed ID: 18191156
    [Abstract] [Full Text] [Related]

  • 5. Systemic IGF-I administration attenuates the inhibitory effect of chronic arthritis on gastrocnemius mass and decreases atrogin-1 and IGFBP-3.
    López-Menduiña M, Martín AI, Castillero E, Villanúa MA, López-Calderón A.
    Am J Physiol Regul Integr Comp Physiol; 2010 Aug 27; 299(2):R541-51. PubMed ID: 20519361
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Fenofibrate, a PPAR{alpha} agonist, decreases atrogenes and myostatin expression and improves arthritis-induced skeletal muscle atrophy.
    Castillero E, Nieto-Bona MP, Fernández-Galaz C, Martín AI, López-Menduiña M, Granado M, Villanúa MA, López-Calderón A.
    Am J Physiol Endocrinol Metab; 2011 May 27; 300(5):E790-9. PubMed ID: 21304067
    [Abstract] [Full Text] [Related]

  • 8. Ghrelin inhibits skeletal muscle protein breakdown in rats with thermal injury through normalizing elevated expression of E3 ubiquitin ligases MuRF1 and MAFbx.
    Balasubramaniam A, Joshi R, Su C, Friend LA, Sheriff S, Kagan RJ, James JH.
    Am J Physiol Regul Integr Comp Physiol; 2009 Apr 27; 296(4):R893-901. PubMed ID: 19211729
    [Abstract] [Full Text] [Related]

  • 9. AMP-activated protein kinase agonists increase mRNA content of the muscle-specific ubiquitin ligases MAFbx and MuRF1 in C2C12 cells.
    Krawiec BJ, Nystrom GJ, Frost RA, Jefferson LS, Lang CH.
    Am J Physiol Endocrinol Metab; 2007 Jun 27; 292(6):E1555-67. PubMed ID: 17264220
    [Abstract] [Full Text] [Related]

  • 10. Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes.
    Castillero E, Alamdari N, Lecker SH, Hasselgren PO.
    Metabolism; 2013 Oct 27; 62(10):1495-502. PubMed ID: 23866982
    [Abstract] [Full Text] [Related]

  • 11. Short-term growth hormone or IGF-I administration improves the IGF-IGFBP system in arthritic rats.
    López-Menduiña M, Martín AI, Castillero E, Villanúa MA, López-Calderón A.
    Growth Horm IGF Res; 2012 Feb 27; 22(1):22-9. PubMed ID: 22244673
    [Abstract] [Full Text] [Related]

  • 12. Melanocortin-4 receptor agonist (RO27-3225) ameliorates soleus but not gastrocnemius atrophy in arthritic rats.
    Gomez-Sanmiguel AB, Nieto-Bona MP, Fernandez-Galaz C, Priego T, Martin AI, Lopez-Calderon A.
    J Physiol Pharmacol; 2017 Apr 27; 68(2):191-199. PubMed ID: 28614768
    [Abstract] [Full Text] [Related]

  • 13. IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1.
    Sacheck JM, Ohtsuka A, McLary SC, Goldberg AL.
    Am J Physiol Endocrinol Metab; 2004 Oct 27; 287(4):E591-601. PubMed ID: 15100091
    [Abstract] [Full Text] [Related]

  • 14. Upregulation of MuRF1 and MAFbx participates to muscle wasting upon gentamicin-induced acute kidney injury.
    Aniort J, Polge C, Claustre A, Combaret L, Béchet D, Attaix D, Heng AE, Taillandier D.
    Int J Biochem Cell Biol; 2016 Oct 27; 79():505-516. PubMed ID: 27102410
    [Abstract] [Full Text] [Related]

  • 15. [MAFbx and MuRF1 mRNA expression and its relationship with muscular contractility following free muscle transfer].
    Liu AT, Yu DZ, Zhang YF, Zhang WJ, Ding WJ, Ren AJ, Fang CP, Jiang H.
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2009 May 27; 25(3):217-21. PubMed ID: 19803207
    [Abstract] [Full Text] [Related]

  • 16. IGF-I system, atrogenes and myogenic regulatory factors in arthritis induced muscle wasting.
    Castillero E, Martín AI, López-Menduiña M, Granado M, Villanúa MA, López-Calderón A.
    Mol Cell Endocrinol; 2009 Oct 15; 309(1-2):8-16. PubMed ID: 19501629
    [Abstract] [Full Text] [Related]

  • 17. Role of the insulin-like growth factor I decline in the induction of atrogin-1/MAFbx during fasting and diabetes.
    Dehoux M, Van Beneden R, Pasko N, Lause P, Verniers J, Underwood L, Ketelslegers JM, Thissen JP.
    Endocrinology; 2004 Nov 15; 145(11):4806-12. PubMed ID: 15284206
    [Abstract] [Full Text] [Related]

  • 18. Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: an in vitro and in vivo study.
    Yuan L, Han J, Meng Q, Xi Q, Zhuang Q, Jiang Y, Han Y, Zhang B, Fang J, Wu G.
    Oncol Rep; 2015 May 15; 33(5):2261-8. PubMed ID: 25760630
    [Abstract] [Full Text] [Related]

  • 19. Ghrelin improves body weight loss and skeletal muscle catabolism associated with angiotensin II-induced cachexia in mice.
    Sugiyama M, Yamaki A, Furuya M, Inomata N, Minamitake Y, Ohsuye K, Kangawa K.
    Regul Pept; 2012 Oct 10; 178(1-3):21-8. PubMed ID: 22750276
    [Abstract] [Full Text] [Related]

  • 20. Hindlimb casting decreases muscle mass in part by proteasome-dependent proteolysis but independent of protein synthesis.
    Krawiec BJ, Frost RA, Vary TC, Jefferson LS, Lang CH.
    Am J Physiol Endocrinol Metab; 2005 Dec 10; 289(6):E969-80. PubMed ID: 16046454
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.